Diabetes Type 1 Clinical Trial
— FHSOfficial title:
Validation of the French Version of the Three Scales for Assessing the Fear of Type 1 Hypoglycemia (HFS-C, HFS-PYC and HFS-P) in Children, Adolescents and Their Parents by a Monocentric Transverse Psychometric Study
Type 1 diabetes usually appears brutally in children or young adults. While many factors of
poor glycemic balance have been identified in the literature (age, socio-cultural and
socio-economic level, family structure, adherence etc.), it turns out that hypoglycemia is
the most common acute complications. It would be an important physiological and psychological
barrier for the patient and his parents to manage this diabetes, the latter seeking to keep
the blood glucose levels above the objectives in order to avoid the occurrence of a
hypoglycemia, especially nocturnal.
If there is a questionnaire currently validated as a tool to measure the fear of hypoglycemia
(HFS, Hypoglycemia Fear Survey is available in three versions: L'HFS-Child (HFS-C) for
children over 6 years old, HFS-Parents of Young children ( HFS-PYC) for parents of young
children (under 8 years of age) and HFS-Parents (HFS-P)) for parents of children over 8 years
of age, on the other hand, there are no French and no French studies have evaluated the
prevalence and impact of the fear of hypoglycemia in French patients with type 1 diabetes.
It is therefore essential to use a reliable and valid tool to identify patients affected by
the fear of hypoglycemia, which can be an obstacle to improve glycemic control and to an
optimum quality of life. Having a tool in French and validated on the scientific level would
allow to propose adapted therapeutic treatments (psychological follow-up, individual or
collective sessions of therapeutic education, material assistance (sensor of blood glucose,
pump with insulin stop...) In order to both improve metabolic balance while increasing the
quality of life of patients by lowering secondary anxiety to hypoglycemia
Status | Recruiting |
Enrollment | 210 |
Est. completion date | December 3, 2020 |
Est. primary completion date | December 3, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 2 Years to 18 Years |
Eligibility |
Inclusion Criteria: - Age between 2 and 18 years - Type 1 diabetes defined by an hyperglycemia higher than 2g/l, polyuria, polydipsia and positive antibody - insulin-treated type 2 diabetes by daily injections or insulin pump Exclusion Criteria: - Trouble to read - Trouble to understand - Trouble to answer to the questionnaire - Opposition. |
Country | Name | City | State |
---|---|---|---|
France | CHRU de Brest | Brest | |
France | Centre Hospitalier de Bretagne Sud | Lorient | |
France | Hôpital Universitaire Robert-Debré | Paris cedex 19 |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Brest |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | HFS-Child score, | Change of Behaviour adopted by the patient in order to avoid the occurrence of hypoglycemia and worry about low blood sugar | Month 0 | |
Primary | HFS-PYC score | Change in Anxiety related to the phenomenon of hypoglycemia | Month 0, Month 3 (+/- 30 days) | |
Primary | HFS-Parent score | Change of Behaviour adopted by the parent in order to avoid the occurrence of hypoglycemia | Month 0, Month 3 (+/- 30 days) | |
Secondary | Questionnaire Survey "children " | Diabetes impact on relationships, activity, alimentation ... " children" | Month 0, Month 3 (+/- 30 days) | |
Secondary | Questionnaire Survey "parents " | Diabetes impact on relationships, activity, alimentation ... " parents" | Month 0, Month 3 (+/- 30 days) | |
Secondary | HbA1C | percentage value | Month 0, Month 3 (+/- 30 days) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02546401 -
Comparison of Insulin's Injection Before or After the Meal in Type 1 Diabetic Patients Treated With Insulin Pump
|
Phase 3 | |
Enrolling by invitation |
NCT06207838 -
Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump
|
N/A | |
Withdrawn |
NCT02057497 -
An Exploratory Clinical Trial to Generate Whole Blood Samples for Analysing Genetic Polymorphisms
|
N/A | |
Active, not recruiting |
NCT05088616 -
Native American Diabetes Project
|
N/A | |
Withdrawn |
NCT01501032 -
Inpatient Evaluation of the MD-Logic Artificial Pancreas System in Patients With Type 1 Diabetes
|
Phase 1 | |
Completed |
NCT01770561 -
Feasibility Study of an Integrated Sensor and Infusion Set
|
N/A | |
Completed |
NCT00417131 -
Imaging of Islet Transplantation With PET and MRT
|
N/A | |
Completed |
NCT03538106 -
Factors Associated With Cesarean Delivery in Women With Type 1 Diabetes
|
||
Completed |
NCT01565824 -
Web-based Support During Pregnancy and Early Motherhood in Women With Type 1 Diabetes (MODIAB-web)
|
N/A | |
Recruiting |
NCT04257877 -
Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD)
|
||
Withdrawn |
NCT01322321 -
ACZ885 in Type 1 Diabetes Mellitus
|
Phase 2 | |
Active, not recruiting |
NCT04794283 -
Antenatal Hand Milking for Pregnant Women With Diabetes'
|
||
Completed |
NCT03842683 -
CGM Precision and Glycaemic Variability
|
||
Suspended |
NCT04874532 -
A Study to Improve Diabetes Management Among Adults Experiencing Severe Hypoglycemia
|
N/A | |
Terminated |
NCT00925977 -
Treatment Satisfaction of Insulin Glargine Plus Insulin Apidra Compared With NPH Insulin Plus Insulin Apidra in Recently Diagnosed Type 1 Diabetes Children and Adolescents
|
N/A | |
Completed |
NCT02066350 -
Cardiovascular Risk Factors After Single Pancreas Transplantation
|
N/A | |
Completed |
NCT02137174 -
Home and School Visits Intervention for Children With DM TYPE 1
|
Phase 2/Phase 3 | |
Completed |
NCT06365255 -
National Epidemiological Study of the Possible Impact of Stress on Glycaemic Control in Patients With Type 1 Diabetes
|
||
Completed |
NCT03433677 -
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
|
Phase 3 | |
Completed |
NCT04587297 -
Food Collection From Type 1 Diabetic Patients Practicing Insulin Functional Therapy
|